N. Furuya

发表

Fosfomycin Alters Lipopolysaccharide-Induced Inflammatory Cytokine Production in Mice

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1999, Antimicrobial Agents and Chemotherapy.

Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa.

K. Tateda, N. Furuya, A. Ohno, 1999, Cytokine.

Effect of Interleukin-10 on Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1998, Antimicrobial Agents and Chemotherapy.

Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice

K. Tateda, S. Miyazaki, N. Furuya, 1997, Antimicrobial agents and chemotherapy.

Molecular Epidemiological Analysis of the Spreading Conditions of Trichophyton in Long-Term Care Facilities in Japan.

N. Furuya, S. Suzuki, Y. Mano, 2018, Japanese journal of infectious diseases.

Discovery of Terbinafine Low Susceptibility Trichophyton rubrum strain in Japan.

N. Furuya, S. Suzuki, Y. Mano, 2018, Biocontrol science.

Realities and Challenges of Bridging Research in Japan

N. Furuya, K. Makimura, Y. Mano, 2020 .

Identification of biochemically atypical Staphylococcus aureus clinical isolates with three automated identification systems.

Tetsuya Matsumoto, K. Tateda, N. Furuya, 2006, Journal of medical microbiology.

Slightly acidic electrolyzed water disrupts biofilms and effectively disinfects Pseudomonas aeruginosa.

Tetsuya Matsumoto, N. Furuya, K. Ohkusu, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer

A. Gemma, M. Seike, K. Kubota, 2022, Thoracic cancer.

Effect of Antiflagellar Human Monoclonal Antibody on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1999, Clinical Diagnostic Laboratory Immunology.

In Vitro and In Vivo Antibacterial Activities of L-084, a Novel Oral Carbapenem, against Causative Organisms of Respiratory Tract Infections

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 2001, Antimicrobial Agents and Chemotherapy.

Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia

M. Kaku, Tetsuya Matsumoto, K. Tateda, 1991, Infection and immunity.

Effect of clearance of bacteria from the blood on the development of systemic bacteraemia in mice.

M. Kaku, K. Tateda, N. Furuya, 1993, Journal of medical microbiology.

Serum Cytokines in Patients withLegionella Pneumonia: Relative Predominance of Th1-Type Cytokines

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1998, Clinical Diagnostic Laboratory Immunology.

Detection of Antibody‐Coated Bacteria in Expectorated Sputum for Diagnosis of Lower Respiratory Infections

M. Kaku, K. Tateda, N. Furuya, 1994, Microbiology and immunology.

In Vivo Antibacterial Activities of Sanfetrinem Cilexetil, a New Oral Tricyclic Antibiotic

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1998, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1998, Antimicrobial Agents and Chemotherapy.

THE COMPARISON OF SUSCEPTIBILITY TO ENDOGENOUS PSEUDOMONAS AERUGINOSA SEPTICEMIA BETWEEN ENDOTOXIN RESPONDER AND NON-RESPONDER MICE

M. Kaku, N. Furuya, K. Yamaguchi, 1996 .

[Clinical and diagnostic characteristics of Legionella pneumonia].

K. Tateda, N. Furuya, Y. Ishii, 1997, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Adherence to and Penetration of Human Intestinal Caco-2 Epithelial Cell Monolayers by Pseudomonas aeruginosa

Yasuaki Yamada, S. Kamihira, S. Kohno, 1998, Infection and Immunity.

Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa.

K. Tateda, N. Furuya, A. Ohno, 1999, Journal of medical microbiology.

Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.

K. Tateda, S. Miyazaki, N. Furuya, 1998, Journal of medical microbiology.

In vitro and in vivo antibacterial activities of quinupristin-dalfopristin, a novel injectable streptogramin, against gram-positive cocci and gram-negative respiratory tract pathogens

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1998 .

Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.

N. Furuya, Y. Mano, T. Oguri, 2012, The Japanese journal of antibiotics.

Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

K. Tateda, S. Miyazaki, N. Furuya, 1996, Antimicrobial agents and chemotherapy.

Amphotericin B-induced resistance to Pseudomonas aeruginosa infection in mice.

M. Kaku, K. Tateda, N. Furuya, 1993, The Journal of antibiotics.

Epidemiological Study on Trichophyton Disseminating from the Feet of the Elderly.

N. Furuya, S. Suzuki, Y. Mano, 2017, Nihon eiseigaku zasshi. Japanese journal of hygiene.

Primary Shewanella alga Septicemia in a Patient on Hemodialysis

Tetsuya Matsumoto, K. Tateda, N. Furuya, 1999, Journal of Clinical Microbiology.

Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources.

M. Kaku, Tetsuya Matsumoto, K. Tateda, 1993, Journal of medical microbiology.

In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections

K. Tateda, N. Furuya, A. Ohno, 1997, Antimicrobial agents and chemotherapy.

Role of motility in the endogenousPseudomonas aeruginosa sepsis after burn

Tetsuya Matsumoto, K. Tateda, N. Furuya, 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa

S. Kohno, M. Kaku, N. Furuya, 1994, Antimicrobial Agents and Chemotherapy.

Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa

M. Kaku, Tetsuya Matsumoto, K. Tateda, 1992, Antimicrobial Agents and Chemotherapy.

Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice

M. Kaku, Tetsuya Matsumoto, K. Tateda, 1992, Antimicrobial Agents and Chemotherapy.

Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.

K. Tateda, S. Miyazaki, N. Furuya, 1998, Journal of medical microbiology.

Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa

K. Tateda, N. Furuya, A. Ohno, 1993, Antimicrobial Agents and Chemotherapy.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].

H. Uchida, T. Deguchi, S. Kamidono, 2006, The Japanese journal of antibiotics.

Surveillance of susceptibility of 2,228 clinical isolates to gatifloxacin and various antimicrobial agents

S. Ichiyama, M. Yasujima, M. Kaku, 2004 .

Influence of various immunosuppressive agents on the occurrence of endogenous bacteraemia in mice.

K. Tateda, N. Furuya, Y. Hirakata, 1995, Journal of medical microbiology.

In-vitro activities of 11 antibiotics against vancomycin-resistant enterococci isolated in Japan.

K. Tateda, N. Furuya, A. Ohno, 1999, The Journal of antimicrobial chemotherapy.

Bacterial translocation of intestinalPseudomonas aeruginosa in post-burn infection of mice

Tetsuya Matsumoto, K. Tateda, N. Furuya, 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice

M. Kaku, K. Tateda, N. Furuya, 1993, Infection and immunity.

In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem

Tetsuya Matsumoto, K. Tateda, S. Miyazaki, 1998, Antimicrobial Agents and Chemotherapy.

[A case of falciparum malaria successfully treated with intravenous artesunate].

Tetsuya Matsumoto, K. Tateda, N. Furuya, 2001, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice.

K. Tateda, N. Furuya, A. Ohno, 2001, The Journal of antimicrobial chemotherapy.

In vitro antimicrobial activities of a novel everninomicin for multiple drug-resistant Streptococcus pneumoniae isolates in Japan.

K. Tateda, N. Furuya, A. Ohno, 2001, The Journal of antimicrobial chemotherapy.

Lipoolygosaccharide indirectly enhances inflammatory lesions in lungs as a primary infection site by non-encapsulated and type B Haemophilus influenzae through production of cytokines.

T. Nunoya, K. Tateda, S. Miyazaki, 2001, Cytokine.

Prevalence of Antimicrobial Resistance in Haemophilus influenzae and Streptococcus pneumoniae : Comparison of Clinical Isolates of Japan and The Philippines

T. Tupasi, K. Tateda, N. Furuya, 1993 .

[Effect of macrolide antibiotics on human serum-bactericidal sensitivity of Pseudomonas aeruginosa S-6].

K. Tateda, N. Furuya, A. Ohno, 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Assessment of clinical significance of positive blood cultures of relatively low-virulence isolates.

M. Kaku, K. Tateda, N. Furuya, 1996, Journal of medical microbiology.

A protective role for lymphocytes in cyclophosphamide-induced endogenous bacteraemia in mice.

K. Tateda, N. Furuya, Y. Hirakata, 1995, Journal of medical microbiology.

Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.

K. Tateda, N. Furuya, Y. Hirakata, 1996, Journal of medical microbiology.

Experimental endogenous septicaemia caused by-KlebsieIla pneumoniae and Escherichia coli

K. Tateda, N. Furuya, K. Yamaguchi, 2022 .

[Susceptibility testing of clinical strains of Legionella spp. isolated in Japan].

K. Tateda, N. Furuya, K. Yamaguchi, 2001, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Evaluation of clinical usefulness of the microplate agglutination test for serological diagnosis of legionella pneumonia.

K. Tateda, N. Furuya, Y. Ishii, 1998, Journal of Medical Microbiology.

[Role of capsular polysaccharide and lipopolysaccharide of Klebsiella pneumoniae in experimental mice pneumonia model].

M. Kaku, K. Tateda, N. Furuya, 1992, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

The influence of exo-enzyme S and proteases on endogenous Pseudomonas aeruginosa bacteraemia in mice.

K. Tateda, N. Furuya, Y. Hirakata, 1995, Journal of medical microbiology.

Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis.

K. Tateda, N. Furuya, A. Ohno, 1997, Cytokine.